OSA Endotypes: What Are They and What Are Their Potential Clinical Implications?
Purpose of the Review
To review critically the different mechanisms, or endotypes, causing obstructive sleep apnea (OSA) in individual patients, and their potential implications for management.
Currently, at least four underlying mechanisms that contribute to OSA have been identified, namely a compromised upper airway anatomy, a poor pharyngeal muscle responsiveness, respiratory control instability (high loop gain), and a low arousal threshold (wake up too easily); the relative contributions of these four traits in an individual form their endotype. Endotypes provide therapeutic targets that may facilitate development of novel therapies, can predict treatment response to non-CPAP therapies, and may explain clinical phenotypes. Endotyping is currently restricted to specialized research laboratories, but newer methods relying on standard polysomnography may soon allow routine assessment of endotypes as part of clinical practice.
Endotyping promises to transform the current one-size fits-all OSA management into an individualized precision medicine approach in the future.
KeywordsObstructive sleep apnea Endotype Phenotype Pathogenesis Mechanisms Management
Compliance with Ethical Standards
Conflict of Interest
Christopher N. Schmickl declares no conflicts of interest.
Robert L. Owens reports personal fees from Novartis, personal fees from ResMed, personal fees from Itamar.
Bradley A. Edwards grants from Heart Foundation of Australia.
Atul Malhotra relinquished all outside personal income in 2012 as an Officer of the American Thoracic Society. Resmed provided a philanthropic donation to the UC San Diego in support of a sleep center.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Robert L. Owens is supported by NHLBI R01 HL142114–01. Bradley A. Edwards is supported by a Heart Foundation of Australia Future Leader Fellowship (101167).
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major Importance
- 9.• Keenan BT, Kim J, Singh B, Bittencourt L, Chen NH, Cistulli PA, et al. Recognizable clinical subtypes of OSA across a worldwide sleep center population: a cluster analysis. Sleep. 2018; https://doi.org/10.1093/sleep/zsx214. This study reaffirmed the existence of three previously identified phenotypes and identified two new ones
- 11.•• Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med. 2013;188(8):996–1004. https://doi.org/10.1164/rccm.201303-0448OC. Landmark physiologic study of a large sample suggesting that non-anatomical traits contribute to OSA pathogenesis in 70% of patients. CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Schwab RJ, Pasirstein M, Pierson R, Mackley A, Hachadoorian R, Arens R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med. 2003;168(5):522–30. https://doi.org/10.1164/rccm.200208-866OC.CrossRefPubMedGoogle Scholar
- 20.Stadler DL, McEvoy RD, Bradley J, Paul D, Catcheside PG. Changes in lung volume and diaphragm muscle activity at sleep onset in obese obstructive sleep apnea patients vs. healthy-weight controls. J Appl Physiol (Bethesda, Md: 1985). 2010;109(4):1027–36. https://doi.org/10.1152/japplphysiol.01397.2009.CrossRefGoogle Scholar
- 23.• Genta PR, Sands SA, Butler JP, Loring SH, Katz ES, Demko BG, et al. Airflow shape is associated with the pharyngeal structure causing OSA. Chest. 2017;152(3):537–46. https://doi.org/10.1016/j.chest.2017.06.017. Development of a new method to identify the level of upper airway collapse non-invasively, which may help guide management in the future. CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009;169(17):1619–26. https://doi.org/10.1001/archinternmed.2009.266. CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Newell J, Mairesse O, Neu D. Can positional therapy be simple, effective and well tolerated all together? A prospective study on treatment response and compliance in positional sleep apnea with a positioning pillow. Sleep Breath. 2018; https://doi.org/10.1007/s11325-018-1650-6.
- 29.Ravesloot MJL, White D, Heinzer R, Oksenberg A, Pepin JL. Efficacy of the new generation of devices for positional therapy for patients with positional obstructive sleep apnea: a systematic review of the literature and meta-analysis. J Clin Sleep Med. 2017;13(6):813–24. https://doi.org/10.5664/jcsm.6622. CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Eckert DJ, Lo YL, Saboisky JP, Jordan AS, White DP, Malhotra A. Sensorimotor function of the upper-airway muscles and respiratory sensory processing in untreated obstructive sleep apnea. J Appl Physiol (Bethesda Md: 1985). 2011;111(6):1644–53. https://doi.org/10.1152/japplphysiol.00653.2011.CrossRefGoogle Scholar
- 42.Woodson BT, Strohl KP, Soose RJ, Gillespie MB, Maurer JT, de Vries N, et al. Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Head Neck Surg. 2018; https://doi.org/10.1177/0194599818762383.
- 43.• Strollo PJ Jr, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014;370(2):139–49. https://doi.org/10.1056/NEJMoa1308659. Landmark trial showing efficacy of hypogloassal nerve stimulation in select patients, with randomized withdrawal of therapy in responders to further validate the results. CrossRefPubMedGoogle Scholar
- 44.• Carley DW, Prasad B, Reid KJ, Malkani R, Attarian H, Abbott SM et al. Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE Clinical Trial: effects of dronabinol in obstructive sleep apnea. Sleep. 2018;41(1). https://doi.org/10.1093/sleep/zsx184. New pharmacological class shown to improve sleep apnea possibly due to improved pharyngeal muscle responsiveness and/or ventilatory stability.
- 46.• Taranto-Montemurro L, Sands SA, Edwards BA, Azarbarzin A, Marques M, de Melo C, et al. Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation. Eur Respir J. 2016;48(5):1340–50. https://doi.org/10.1183/13993003.00823-2016. Physiologic trial showing improved pharyngeal muscle response with Desipramine, but at the cost of generally also lowering arousal threshold, thus improved AHI seems to be limited to patients with poor pharyngeal muscle responsiveness at baseline. CrossRefPubMedPubMedCentralGoogle Scholar
- 52.• Lloyd BB, Jukes MG, Cunningham DJ. The relation between alveolar oxygen pressure and the respiratory response to carbon dioxide in man. Q J Exp Physiol Cogn Med Sci. 1958;43(2):214–27. Landmark study demonstrating relationships between oxygen, carbon dioxide levels, and ventilation. PubMedGoogle Scholar
- 58.Edwards BA, Sands SA, Skuza EM, Stockx EM, Brodecky V, Wilkinson MH, et al. Increased peripheral chemosensitivity via dopaminergic manipulation promotes respiratory instability in lambs. Respir Physiol Neurobiol. 2008;164(3):419–28. https://doi.org/10.1016/j.resp.2008.09.003.CrossRefPubMedGoogle Scholar
- 59.• Edwards BA, Sands SA, Eckert DJ, White DP, Butler JP, Owens RL, et al. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. J Physiol. 2012;590(5):1199–211. https://doi.org/10.1113/jphysiol.2011.223925. Physiological trial demonstrating that acetazolamide can reduce plant, and thus loop gain. CrossRefPubMedPubMedCentralGoogle Scholar
- 64.• Sands SA, Edwards BA, Kee K, Turton A, Skuza EM, Roebuck T, et al. Loop gain as a means to predict a positive airway pressure suppression of Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med. 2011;184(9):1067–75. https://doi.org/10.1164/rccm.201103-0577OC. Small study demonstrating that CPAP can lower loop gain and reduce central sleep apnea severity (presumably through lung volume effects). CrossRefPubMedGoogle Scholar
- 78.•• Younes M. Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med. 2004;169(5):623–33. https://doi.org/10.1164/rccm.200307-1023OC. Large landmark physiologic study challenging the common believe of arousals as a necessity for the upper airway opening. CrossRefPubMedGoogle Scholar
- 83.• Edwards BA, Eckert DJ, McSharry DG, Sands SA, Desai A, Kehlmann G, et al. Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2014;190(11):1293–300. https://doi.org/10.1164/rccm.201404-0718OC. Example of an approach to assess endotypes via readily available clinical data. CrossRefPubMedPubMedCentralGoogle Scholar
- 84.• Eckert DJ, Owens RL, Kehlmann GB, Wellman A, Rahangdale S, Yim-Yeh S, et al. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Respirology (Carlton, Vic). 2011;120(12):505–14. https://doi.org/10.1111/resp.1304410.1042/cs20100588. Physiologic trial showing that ezcopiclone can increase arousal threshold and reduce AHI. CrossRefGoogle Scholar
- 86.• Smales ET, Edwards BA, Deyoung PN, McSharry DG, Wellman A, Velasquez A, et al. Trazodone effects on obstructive sleep apnea and non-REM arousal threshold. Ann Am Thorac Soc. 2015;12(5):758–64. https://doi.org/10.1513/AnnalsATS.201408-399OC. Physiologic trial showing that trazodone can increase arousal threshold and reduce AHI. CrossRefPubMedPubMedCentralGoogle Scholar
- 88.Carberry JC, Fisher LP, Grunstein RR, Gandevia SC, McKenzie DK, Butler JE, et al. Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem. Eur Respir J. 2017;50(6):1701344. https://doi.org/10.1183/13993003.01344-2017. CrossRefPubMedGoogle Scholar
- 89.• Kaur S, Wang JL, Ferrari L, Thankachan S, Kroeger D, Venner A, et al. A genetically defined circuit for arousal from sleep during hypercapnia. Neuron. 2017;96(5):1153–67.e5. https://doi.org/10.1016/j.neuron.2017.10.009. Animal study revealing potentially new target for arousal suppression in the future. CrossRefPubMedGoogle Scholar
- 91.Taranto-Montemurro L, Sands SA, Edwards BA, Azarbarzin A, Marques M, de Melo C, Eckert DJ, White DP, Wellman A. Effects of tiagabine on slow wave sleep and arousal threshold in patients with obstructive sleep apnea. Sleep. 2017;40(2). https://doi.org/10.1093/sleep/zsw047.
- 94.Kirkness JP, Madronio M, Stavrinou R, Wheatley JR, Amis TC. Relationship between surface tension of upper airway lining liquid and upper airway collapsibility during sleep in obstructive sleep apnea hypopnea syndrome. J Appl Physiol (Bethesda, Md: 1985). 2003;95(5):1761–6. https://doi.org/10.1152/japplphysiol.00488.2003.CrossRefGoogle Scholar
- 95.•• Sands SA, Edwards BA, Terrill PI, Taranto-Montemurro L, Azarbarzin A, Marques M, et al. Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2018; https://doi.org/10.1164/rccm.201707-1435OC. Development of a computational method to reveal traits based on standard polysomnographic data which may facilitate clinical endotyping in the future.
- 97.Wellman A, Eckert DJ, Jordan AS, Edwards BA, Passaglia CL, Jackson AC, et al. A method for measuring and modeling the physiological traits causing obstructive sleep apnea. J Appl Physiol (Bethesda, Md: 1985). 2011;110(6):1627–37. https://doi.org/10.1152/japplphysiol.00972.2010.CrossRefPubMedCentralGoogle Scholar
- 100.Landry SA, Joosten SA, Eckert DJ, Jordan AS, Sands SA, White DP, Malhotra A, Wellman A, Hamilton GS, Edwards BA. Therapeutic CPAP level predicts upper airway collapsibility in patients with obstructive sleep apnea. Sleep. 2017;40(6). https://doi.org/10.1093/sleep/zsx056.
- 101.Landry SA, Joosten SA, Sands SA, White DP, Malhotra A, Wellman A, et al. Response to a combination of oxygen and a hypnotic as treatment for obstructive sleep apnoea is predicted by a patient’s therapeutic CPAP requirement. Respirology. 2017;22(6):1219–24. https://doi.org/10.1111/resp.13044.CrossRefPubMedPubMedCentralGoogle Scholar
- 102.Kobayashi M, Namba K, Tsuiki S, Matsuo A, Sugiura T, Inoue Y. Clinical characteristics in two subgroups of obstructive sleep apnea syndrome in the elderly: comparison between cases with elderly and middle-age onset. Chest. 2010;137(6):1310–5. https://doi.org/10.1378/chest.09-2251. CrossRefPubMedPubMedCentralGoogle Scholar
- 103.Joosten SA, Leong P, Landry SA, Sands SA, Terrill PI, Mann D, Turton A, Rangaswamy J, Andara C, Burgess G, Mansfield D, Hamilton GS, Edwards BA. Loop gain predicts the response to upper airway surgery in patients with obstructive sleep apnea. Sleep. 2017;40(7). https://doi.org/10.1093/sleep/zsx094.
- 104.Edwards BA, Andara C, Landry S, Sands SA, Joosten SA, Owens RL, et al. Upper-airway collapsibility and loop gain predict the response to oral appliance therapy in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2016;194(11):1413–22. https://doi.org/10.1164/rccm.201601-0099OC.CrossRefPubMedPubMedCentralGoogle Scholar
- 106.Stanchina M, Robinson K, Corrao W, Donat W, Sands S, Malhotra A. Clinical use of loop gain measures to determine continuous positive airway pressure efficacy in patients with complex sleep apnea. A pilot study. Ann Am Thorac Soc. 2015;12(9):1351–7. https://doi.org/10.1513/AnnalsATS.201410-469BC.CrossRefPubMedPubMedCentralGoogle Scholar
- 107.Zinchuk A, Edwards BA, Jeon S, Koo BB, Concato J, Sands S et al. Prevalence, associated clinical features, and impact on continuous positive airway pressure use of a low respiratory arousal threshold among male United States veterans with obstructive sleep apnea. J Clin Sleep Med. 2018.Google Scholar